Genmark Diagnositics is a 2011 IPO that has been a huge winner that keeps forming base after base. We can trade or own this against 10. Targets include 11.75 and 14. Note that earnings are March 12th after the close.
Thanks for reading. To show my appreciation, I'll start adding reader exclusives to blog posts. No mentions on twitter, only here.
Check out this PHMD. On Monday (2/4) there was an unusual volume surge. The stock has traded in a very tight weekly pattern after a 50% gain off of the November lows. The key here is a very high short ratio of 25. The current buy point is at 15.55. This reports earnings in the morning on 3/13.
No comments:
Post a Comment